Peptides

Ultima-Prostamax 20mg – UltimaPeptides USA

Ultima-Prostamax 20mg – UltimaPeptides USA is a bioregulatory peptide complex from Khavinson targeting prostate tissue. This research-grade compound modulates gene expression in prostate epithelial and stromal cells in preclinical research on prostate aging, tissue repair and anti-inflammatory action.

$93.60

Prostamax peptide is a synthetic bioregulatory peptide complex developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. Prostamax targets prostate tissue, acting as a prostate bioregulator that modulates gene expression in prostate epithelial cells, stromal cells, and supporting glandular tissue. It belongs to the Khavinson class of bioregulatory peptides—short regulatory peptides that exhibit tissue-specific modulation of gene expression at physiological concentrations—and has been studied in preclinical models investigating age-related prostatic changes, prostate tissue repair, chronic prostatic inflammation, and aging of the male reproductive tract.